Results for the Third Quarter 2014

Sales for the quarter ended at MNOK 52.0 (MNOK 44.3), a growth of 17 %. Sales as of September ended at MNOK 148.7 (MNOK 138.8), a growth of 7.1 %.
• Continued strong growth in the US with 16.2 % increase in sales for the quarter.
• The consumable sales of probes outside the US increased with 29.3 % for the quarter and 16.4 % year to date.
• Operating profit (EBIT) for the quarter ended at MNOK 10.0 (MNOK 6.5), a growth of 54.1 %. Year to date operating profit ended at MNOK 28.9 (MNOK 26.6), a growth of 8.6 %.
• The new product MiraQTM Cardiac with new functionality that increases the value for the cardiac surgeons, was launched at Annual European Association for Cardiac-Thoracic Surgery (EACTS)
3. quarter
2014

Medistim ASA Q3 2014 Presentation

3 quarter 2014